New Web-Based therapy aims to cure insomnia in persian speakers
NCT ID NCT07431034
First seen Jun 25, 2026 · Last updated Aug 20, 2026 · Updated 3 times
Summary
This study tested whether a Persian-language internet program called Omid, based on cognitive behavioral therapy, can improve sleep in adults with insomnia. Thirty participants were randomly assigned to use the program or receive usual care. The program includes weekly online lessons and a sleep diary. Researchers measured changes in insomnia severity, sleep quality, and daytime sleepiness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Omid internet-based cognitive behavioral therapy for insomnia (ICBT-I) program
- What this could lead to
- If it works, this could offer a convenient, accessible treatment option for Persian-speaking adults with insomnia, potentially reducing reliance on sleep medications.
- What could go wrong
- This is a small, early-stage trial with only 30 participants, so results may not apply to everyone. The control group receives no active treatment, and the program's effectiveness may depend on user engagement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Feb 2026
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 60 years. * Meets diagnostic criteria for insomnia disorder according to DSM-5, based on clinical interview or a validated screening procedure. * Insomnia Severity Index (ISI) score ≥ 10, indicating at least subthreshold insomnia. * Reports difficulty initiating or maintaining sleep or early-morning awakenings at least three nights per week for at least three months, with associated daytime impairment (e.g., fatigue, concentration problems, irritability). * Able to read and understand Persian. * Has regular access to the internet and a smartphone and/or computer to use the Omid web-based program. * Willing and able to provide informed consent and to complete online questionnaires and daily sleep diaries. Exclusion Criteria: * Uncontrolled medical or neurological conditions that significantly interfere with sleep or require immediate treatment (e.g., untreated moderate-to-severe obstructive sleep apnea, uncontrolled epilepsy, unstable cardiac disease, advanced cancer). * Current shift work or rotating work schedules that regularly disrupt nighttime sleep. * Pregnancy. * Participation in another clinical trial or research study that could affect sleep during the study period. * Ongoing structured psychotherapy specifically targeting insomnia or other major psychiatric conditions within the past 6 months. * Current major depressive disorder or other severe psychiatric disorder (e.g., bipolar disorder, schizophrenia, psychotic disorders), as determined by clinical assessment or structured interview. * Evidence of problematic substance use, such as heavy alcohol use (more than approximately 3 standard drinks per day on most days of the month) or frequent misuse of recreational drugs (e.g., cannabis use more than once per week), in the judgment of the investigators. * Active suicidal ideation or behavior requiring urgent clinical intervention. * Primary diagnosis of another untreated sleep disorder (e.g., restless legs syndrome, narcolepsy, circadian rhythm sleep-wake disorder) where insomnia is not the main problem. * Having an infant or child under 2 years of age whose care regularly disrupts nighttime sleep, in the judgment of the investigators.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic insomnia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shahid Beheshti University of Medical Sciences
Tehran, Iran
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can talk therapy for sleep beat cancer fatigue?
- Fixing sleep may unlock better weight loss: a trial tests the combo
- Massage therapy may offer a Drug-Free path to better sleep
- Can a gentle brain zapping technique rewire sleep?
- Sleep clinic study aims to uncover best practices for treating insomnia and body clock disorders
- Can a sleep app help save teens from suicide?